Table 1

Summary of the included studies

First authorPatients (n)Deaths (n)person-yearStudy duration periodCMR (95% CI)Overall SMR (95% CI)SMR male (95% CI)SMR female (95% CI)
Hansen et al (Denmark)398814254207 8621949–199720.46 (19.85 to 21.07)2.89 (2.81 to 2.98)2.66 (2.54 to 2.78)3.14 (3.01 to 3.27)
Torkildsen et al (Norway)2687819835 1201953–20055.63 (4.85 to 6.42)2.66 (2.31 to 9.87)2.23 (1.81 to 9.12)3.11 (2.58 to 3.74)
Ragonese et al (Italy)25*1833041881960–20077.16 (4.60 to 9.71)2.12 (1.32 to 3.46)2.00 (0.89 to 4.46)2.22 (1.23 to 4.00)
Sumelahti et al (Finland)24161421932 1651971–20066.80 (5.90 to 7.70)2.80 (2.60 to 6.15)2.20 (1.90 to 6.16)3.40 (3.00 to 3.90)
Smestad et al (Norway)2338626312 1721972–200521.60 (19.02 to 24.19)2.47 (2.09 to 6.38)2.02 (1.56 to 6.17)2.94 (2.36 to 3.62)
Leray et al (France)2218796823 9061976–20032.84 (2.16 to 3.52)1.30 (1.00 to 8.18)1.10 (0.80 to 8.90)1.50 (1.10 to 2.10)
Kingwell et al (Canada)46917102577 9501980–200713.14 (12.35 to 13.94)2.88 (2.71 to 3.07)2.68 (2.43 to 2.96)3.01 (2.79 to 3.25)
Hirst et al (Wales)2036621856091985–200638.86 (33.80 to 43.92)2.79 (2.44 to 3.18)2.26 (1.79 to 2.85)3.14 (2.67 to 3.69)
Lalmohamed et al (UK)2112706939372001–200817.52 (13.42 to 21.62)3.51 (2.63 to 4.69)2.96 (1.84 to 4.77)3.94 (2.73 to 5.68)
Manouchehrinia et al (UK)279238018 7171994–20124.27 (3.34 to 5.20)1.99 (1.70 to 2.33)2.41 (1.95 to 2.96)1.80 (1.40 to 2.30)
Sadovnick et al (Canada)1623481151972–19852.00 (1.63 to 2.36)†
Zarranz et al (Spain)2812838916 4221987–20115.41 (4.29 to 6.54)2.78 (2.20 to 3.35)†3.26 (2.27 to 4.24)†2.73 (1.94 to 3.51)†
  • *95% CI is calculated.

  • †SMRs from univariate relative risk.

  • CMR, crude mortality rate; SMR, standardised mortality ratio.